All the contract research services offered by BioLink Lifesciences are empowered by systems and individuals that form a beautiful synergy to further surpass the expectations of our sponsors.
Today, we are consistently winning trust of our clients because of our team that brings a collective experience of over 100 Years.
We are home to some of the most brilliant and passionate people who keep chemistry and research close to their hearts.
President & CEO
Manan Patel received his B.S. in Pharmacy from Rajiv Gandhi University of Health Sciences, India and M.S. in pharmaceutics from the Long Island University, Brooklyn, NY. He is also currently pursuing professional PhD in Pharmaceutics from University of the sciences in Philadelphia and expecting graduation in May 2021.
Deanna Nelson, PhD
Chief Scientific Officer
Dr. Nelson is a founder, President of BioLink Life sciences. Since its inception in 2001, BioLink has provided synthesis, analytical, manufacturing, and PM support to health care companies of all sizes from around the world. Dr. Nelson is also a registered U.S, patent agent. Her vision and expertise have landed approx.
$ 1 million in government grant support. She used this funding to successfully develop a pipeline of drug products which promise to enhance patient care for those having chronic diseases.
Dr. Kailas Thakker, PhD
Dr. Kailas Thakker’s career in the pharmaceutical industry has spanned for more than 30 years and has expertise in developing and validating analytical methods for a variety of dosage forms. She is a recognized leader in in-vitro release rate and skin permeation testing and her on-going work on the advisory panel of USP has resulted in the issuance of new testing methods for topical dosage forms.
Pardeep Gupta, PhD
Dr. Gupta has spent nearly 26 years at University of the Sciences in Philadelphia, teaching undergraduate and graduate courses in controlled drug delivery systems, pharmaceutical solutions, drug stability, drug diffusion and pharmaceutical rate processes. Before coming to Sciences, he received his doctorate degree in pharmaceutics from the University of Wisconsin Madison. For the past 20 years, he has focused his academic research on delivery of proteins and poorly soluble drugs. Current projects in his laboratory are in the area of nanoparticle-based protein delivery systems, use of amphiphilic peptides as stabilizers of nano suspensions, and design of peptide drugs. He has served on editorial board of Remington. The Science and Practice of Pharmacy and authored several chapters in Remington and other reference books. Dr. Gupta is a member of several professional organizations, including the American Association for the Advancement of Science, American Chemical Society and the American Association of Pharmaceutical Scientists.